SANDOZ 620 (Rivastigmine Tartrate 4.5 mg)

Pill with imprint SANDOZ 620 is Red, Capsule-shape and has been identified as Rivastigmine Tartrate 4.5 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Rivastigmine is used in the treatment of alzheimer's disease; parkinson's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 4.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for SANDOZ 620

Save up to 80% off prescription medications

Click here for your free Discount Card

Rivastigmine Tartrate

Imprint

SANDOZ 620

Strength

4.5 mg

Color

Red

Size

18.00 mm

Shape

Capsule-shape

Availability

Prescription only

Drug Class

Cholinesterase inhibitors

Pregnancy Category

B - No proven risk in humans

CSA Schedule

Not a controlled drug

Labeler / Supplier

Sandoz Pharmaceuticals Inc.

National Drug Code (NDC)

00781-2616

Inactive Ingredients

gelatin, hypromelloses, magnesium stearate, microcrystalline cellulose, ferric oxide red, silicon dioxide, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer